Диссертация (1154667), страница 25
Текст из файла (страница 25)
Basis for the barrier abnormality in atopic dermatitis:outside-inside-outside pathogenic mechanisms/ P. Elias, W. Hatano // J.Allergy Clin. Immunol. 2008; 121: 1337-1343.195.Enamandram, M. Psoriasis epidemiology: the interplay of genes andthe environment./ Enamandram M., Kimball A.B. // J Invest Dermatol 2013;133: 2: 287-289.196.Epidemiology of psoriatic arthritis in the population of the UnitedStates / Gelfand J M, Gladman DD, Mease PJ, et al.
// J Am Acad Dermatol.2005;53: 573.169197.Eyrech, R.Immunology of atopic eczma: overcoming the Th1/Th2paradigm / Eyrech R., Novak N. // Allergy. 2013; 68:974-982.198.Extrinsic and intrinsic types of atopic dermatitis/ Tokura Y. et al.// JDermatol Sci 2010; 58: 1: 1-7.199.Farber E.M., Nall L. Epidemiology: natural history and genetics. In:Roenigk Jr HH, Maibach HI, editors.
Psoriasis. New York: Dekker; 1998. p.107—57.200.Forbes L., Salzman R., Spergel J. Food allergies and atopic dermatitis:differentiating myth from reality//Pediatr. Ann. 2009; 38: 84-90.201.Fortes, C. Relationship Between Smoking and the Clinical Severity ofPsoriasis / Cristina Fortes [and other] // Arch Dermatol, 2005.– vol.141.–№12.–1580–1584.URL:http://archderm.ama–assn.org/cgi/content/full/141/12/1580?202.Franchi, C. Association of cyclosporine and 311 nm UVB in thetreatment of moderate to severe forms of psoriasis: new strategicapproach/C. Franchi, G. Cainelli, E. Frigerio //Int. J. Immunopathol.Pharmacol. -2009.
-№ 17. -Р. 401-406.203.Gene-gene interactions between HLA-C, ERAP1, TNFAIP3 andTRAF3IP2 and the risk of psoriasis in the Chinese Han population/ YinX.Y., Zhang R., Cheng H. et al. // Br J Dermatol. 2013 Oct; 169 (4): 941—3.204.Genetic polymorphism in the TRAF3IP2 gene is associated withpsoriasis vulgaris in a Japanese population. / Hayashi M., Hirota T., Saeki H.et al.
// J Dermatol Sci. 2014 Mar; 73 (3): 264—5.205.Genome-wide association study identifies a psoriasis susceptibilitylocus at TRAF3IP2. / Ellinghaus E., Ellinghaus D., Stuart P.E. et al. // NatGenet. 2010 Nov; 42 (11): 991—5.206.Genome-wideassociationanalysisidentifiesthreepsoriasissusceptibility loci / Stuart P.E., Nair R.P., Ellinghaus E. et al. // Nat Genet2010; 42: 1000—1004.170207.Genomewide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways / Nair R.P., Duffin K.C., Helms C. et al. //Nat Genet 2009;41: 199—204.208.Global epidemiology of psoriasis: a systematic review of incidenceand prevalence / Parisi R , Symmons DP , Griffiths CE et al.
// The Journalof Investigative Dermatology. – 2013. – Vol. 133(Is.2) – P. 377-385] DOI:10.1038/jid.2012.339209.Griffiths, C.E. Pathogenesis and clinical features of psoriasis./Griffiths C.E., Barker J.N. // Lancet 2007 Jul 21; 370 (9583): 263—71.210.Gudjonsson, J.E. Psoriasis: 2007 epidemiology. / Gudjonsson J.E.,Elder J.T. //Clin Dermatol; 25: 535—46.211.Guttman-Yassky, E. Contrasting pathogenesis of atopic dermatitis andpsoriasis -Part I. Clinical and pathologic concepts.
/ Guttman-Yassky E.,Nograles K.E., Krueger J.G. //J Allergy Clin Immunol 2011; 127: 11101118.212.Guidelines for treatment of atopic eczema (atopic dermatitis)/ Ring J.,Atomar A., Bieber T. et al. // Journal of the European Academy ofDermatology and Venerology 2012. - Vol.26, Is.8. - Р.1045-1060.213.Guenther L., Gulliver W. Psoriasis comorbidities. J Cutan Med Surg2009; 13: Suppl 2: S77-S87.214.Health-related quality of life in patients with psoriasis / Jankovic S.,Raznatovic M., Marinkovic Jet al.
//J Cutan Med Surg 2011; 15: 1: 29-36.215.Hong, J. The psychosocial and occupational impact of chronic skindisease/ Judith Hong, Bonnie Koo, John Koo //Dermatologic therapy. –2008. – Vol.21, Issue 1. – P.54-59.216.Identification of 15 new psoriasis susceptibility loci highlights the roleof innate immunity/ Tsoi L.C., Spain S.L., Knight J.
et al. // Nat Genet 2012;44: 1341—8.171217.IL-23R gene polymorphism rs2201841 is associated with psoriaticarthritis. / Popadic S., Ramic Z., Medenica Lj. et al. // Int J Immunogenet.Aug 2014; 41 (4): 335—7.218.Japanese patients with psoriasis and atopic dermatitis show distinctpersonality profiles/ Takahashi H.
et al. // J Dermatol 2013; 40: 5: 273-370.219.Jeziorkowska, R. Topical steroid therapy in atopic dermatitis in theoryand practice/ Jeziorkowska R., Sysa-Jędrzejowska A., Samochocki Z.//Author Inform. 2015 Jun.; 32 (3): 162-126220.John, Y. The role of TNF inhibitors in psoriasis therapy: newimplications for associated comorbidities/Yost John, Johann E Gudjonsson//Med. Rep.
-2009. -Vol. 1. -Р. 30.221.Kovalenko, A. Caspase-8 deficiency in epidermal keratinocytestriggers an inflammatory skin disease/Andrew Kovalenko, Jin-Chul Kim,Tae-Bong Kang //JEM. -2009. -Vol. 206, №10. -Р. 2161-2177.222.Kurd, SK. The prevalence of previously diagnosed and undiagnosedpsoriasis in US adults: results from NHANES 2003-2004 / SK. Kurd, JM.Gelfand// J.
Am. AcadDermatol.– 2009.– Feb. 60 (2):218–24. URL:http://reference.medscape.com/medline/abstract/20034760223.Leung DY. New insights into atopic dermatitis: role of skin barrierand immune dysregulation. Allergol Int.2013;62(2):151-161. View ArticlePub Med doi: 10.2332/allergolint.13-RAI-0564.224.Lebwohl, M. Psoriasis. Lancet 2003; 361: 1197—1204.225.Lewin, J.
Atopic dermatitis and the stratum corneum: part 3: theimmune system in atopic dermatitis. / Lewin J., Friedlander S.F., Del RossoJ.Q. //J Clin Aesthet Dermatol. 2013; 6 (12): 37-44.226.Li, W.Smoking and risk of incident psoriatic arthritis in US women. /Li W, Han J, Qureshi AA. //Ann Rheum Dis 2012;71:804–8.227.Lowes M.A., Suarez-Farinas M., Krueger J.G.
Immunology ofpsoriasis. Annu. Rev. Immunol. 2014; 32: 227-255.172228.Lucky, AW. Comparison of micronized formulation of isotretinoin gel0,05% and tretinon gel microsphere 0,1% in young adolescents with acne: apost hoc analysis of efficacy and tolerability data. / Lucky AW, Sugarman J.// Cutis. 2011 Jun; 87(6):305-310.229.Mease,PJ.PsoriaticArthritis:updateonpathophysiology,assessement and management / PJ.
Mease //Ann Rheum Dis. 2011; 70(suppl): 77-84.230.Mechanisms of immune tolerance relevant to food allergy/ Vickery B.P., Scurlock A. M., Jones S. M., Burks A. W. //J Allergy Clin Immunol.2011. Vol. 127 (3). P. 5765-5784.231.Meier, M. Clinical spectrum and severity of psoriasis. / Meier M.,Sheth P.B. //Curr Probl Dermatol 2009; 38: 1-20.232.Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factorfor psoriasis in several ethnic groups and finds interaction with HLA-Cw6 /Riveira-Munoz E., He S.M., Escaram_ıs G. et al. // J Invest Dermatol 2011;131: 1105—9.233.Molecular dissection of psoriasis: integrating genetics and biology/J.T.
Elder, A.T. Bruce, J.E. Gudjonsson et al. // J Invest Dermatol 2010; 130:1213—26.234.Monteleone, G. Psoriasis: from pathogenesis to novel therapeuticapproaches/G. Monteleone, F. Pallone, D. McDonald //Clinical Science. 2011. -№ 120, I-II.
-Р. 1-11.235.Nestle, F.O. Mechanisms of Disease Psoriasis/F.O. Nestle, D.H.Kaplan, J. Barker //N. Engl. J. Med. -2009. -Vol. 361. -P. 496-509.236.Obesity and the risk of psoriatic arthritis: a populationbased study. /Love TJ, Zhu Y, Zhang Y, et al. // Ann Rheum Dis 2012;71:1273–7.237.Obesity in early adulthood as a risk factor for psoriatic arthritis.
/Soltani-Arabshahi R, Wong B, Feng BJ, et al. //Arch Dermatol2010;146:721–6.173238.Parisi, Rosa; Symmons, Deborah P M; Griffiths, Christopher E M;Ashcroft, Darren M//Journal of Investigative Dermatology . Feb2013, Vol.133 Issue 2, p377-385.239.Probiotics and primary prevention of atopic dermatitis^ a meta-analysis of randomized controlled studies / Panduru M., Panduru N.M.,Salavastru C.M., Tiplica G.-S.
// Journal of the European Academy ofDermatology and Venerology 2015. Vol.29, Is.2, p.232-242.240.Psoriatic arthritis sine psoriasis / Olivieri I, Padula A, D’Angelo S,Cutro M S. // J Rheumatol. 2009; Suppl. 83: 28–29241.Psoriasis is associated with increased beta-defensin genomic copynumber. / Hollox E.J. et al. //Nat Genet 2008; 40: 23-25.242.Reitamo, S. Textbook of atopic dermatitis/ Reitamo S., Luger T.,Steinhoff M. Informa, 2008. 589 p.243.Reich, K. The concept of psoriasis as a systemic inflammation:implications for disease management./ Reich, K. // J Eur Acad DermatolVenereol.2012Mar;26Suppl2:3—11.doi:10.1111/j.1468-3083.2011.04410.x.244.Ryan, C.
Research gaps in psoriasis: opportunities for future studies/Ryan C., Korman N.J., Gelfand J.M. // J Am Acad Dermatol 2014: 70 (1):146-167.245.Sicherer, S. Advances in allergic skin disease, anaphylaxis, andhypersensitivity reactions to foods, drugs, and insects/ Sicherer S., Leung D.//J Allergy Clin Immunol. 2013; 131: 55-66.246.SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis(PSORS2) in a Spanish cohort.
/ González-Lara L., Coto-Segura P., PenedoA. et al. // DNA Cell Biol 2013; 32: 10: 601-614.247.Steigleder, G.K. Eosinophilic leucocytes in the skin lesions ofpsoriasis and atopic dermatitis / Steigleder, G.K. and Inderwisch, R.//Arch.Dermatol. Res. -1975. - vol. 254. - P. 253–255 DOI: 10.1007/BF00557966174248.Strohal R., Psoriasis beyond the skin: an expert group consensus onthe management of psoriatic arthritis and common co-morbidities in patientswith moderate-to-severe psoriasis /R. Strohal, B. Kirby, L. Puig on behalf ofthe Psoriasis Expert Panel (G. Girolomoni, K. Kragballe, T. Luger, F.O.Nestle, J.C.
Prinz, M. St_ahle, N. Yawalkar) // Journal of the EuropeanAcademyofDermatologyandVenereology.-24DEC2013DOI: 10.1111/jdv.12350.249.Systematic review, network meta-analysis and economic evaluation ofbiological therapy for the management of active psoriatic arthritis / MatthewRichard Cawson, Stephen Andrew Mitchell, Chris Knight, Henry Wildey,Dean Spurden, Alex Bird, Michelle Elaine Orme // BMC MusculoskeletalDisorders 2014, doi:10.1186/1471-2474-15-26.250.The dermatological consequences of obesity. /Tobin A.M., Ahern T.,Rogers S et al.// Int J Dermatol 2013; 52: 8: 927-932.251.Thomas, CL , The microbiome and atopic eczema: More than skindeep.
/ Thomas CL , Fernández-Peãns P.//The Australasian Journal ofDermatology [2016] DOI: 10.1111/ajd.12435 Version of Record online: 28JAN 2016252.Tomb, R.R. Profile of skin diseases observed in a department ofdermatology (1995-2000)/ Tomb RR , Nassar JS // The Lebanese MedicalJournal.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
